The newly approved oral formulation features a smaller pill size in 1.5mg, 4mg, and 9mg strengths while maintaining the efficacy and safety profile of the previous oral semaglutide version.

Affiliates of funds advised by SK Capital Partners, LP (“SK Capital”), a private investment firm focused on the life sciences, specialty materials, and ingredients sectors announced today they have ...

The U.S. Food and Drug Administration has approved Merck's Idvynso (doravirine/islatravir), a new, once-daily, two-drug ...

The MENA pharmaceutical contract manufacturing market is poised for growth due to the rise in outsourcing trends, fueled by increasing healthcare demands, government localization initiatives, and ...

Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., and Patheon Pharma Services Lead the Industry Oral Solid Dosage Contract Manufacturing Market Oral Solid ...

Syncromune is advancing SYNC-T Therapy SV-102 in the ongoing Phase 2 LEGION-100 study (NCT06533644), which is actively enrolling across multiple sites in the U.S. Please visit www.legion100trial.com ...

By John Vandermosten, CFA NASDAQ: ACHV Achieve Life Sciences, Inc. (NASDAQ: ACHV) generated significant news flow in April, announcing the arrival of a new CEO, substantial new financing, and a ...

NVO and PFE clash as the obesity market heats up, with shifting strategies, pipeline bets and growth pressures reshaping ...

China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that, the Group through its wholly-owned subsidiary entered into an exclusive commercialization and supply agreement ...

The site represents an important addition to Jamjoom Pharma’s manufacturing network and is expected to enhance its production ...